Influence of oral colonization with probiotic E. coli strain after birth on frequency of recurrent infections, allergy and development of some immunologic parameters. Long-term studies;Vliv perorálního osídlení probiotickým kmenem E. coli po narození na výskyt opakovaných infekcí, alergií a vývoj některých imunologických ukazatelů. Výsledky dlouhodobého sledování

Ceska Gynekologie

Volumn 69, Issue SUPPL. 1, 2004, Pages 91-97

  Lodinova Zadnikova, R ^a   Prokesova L ^b   Tlaskalova H ^c   Kocourkova I ^a   Zizka J ^b   Stranak Z ^a  

^a INSTITUTE FOR THE CARE OF MOTHER AND CHILD   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c INSTITUTE OF MICROBIOLOGY   (Czech Republic)

Author keywords

Allegies; Colonization of intestine; Infants; Infections; Prevention; Probiotic E. coli strain

Indexed keywords

COLINFANT; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 4; PROBIOTIC AGENT; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ADULT; ALLERGY; ANTIBODY RESPONSE; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM ISOLATION; CHILD CARE; CLINICAL FEATURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CZECHOSLOVAKIA; EARLY DIAGNOSIS; ESCHERICHIA COLI; EVALUATION; GASTROINTESTINAL TRACT; HIGH RISK PATIENT; HOSPITAL INFECTION; HUMAN; IMMUNE FUNCTION TEST; IMMUNOGLOBULIN PRODUCTION; INCIDENCE; INFANT; INFANT FEEDING; INFECTION PREVENTION; LONG TERM CARE; MAJOR CLINICAL STUDY; MUCOSA; POSTNATAL DEVELOPMENT; RECURRENT INFECTION; STRAIN IDENTIFICATION;

ADMINISTRATION, ORAL; BACTERIAL INFECTIONS; CROSS INFECTION; CYTOKINES; ESCHERICHIA COLI; FOLLOW-UP STUDIES; GASTROINTESTINAL TRACT; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN A, SECRETORY; INFANT, NEWBORN; PROBIOTICS;

EID: 12344271967     PISSN: 12107832     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Adlerberth I., Carlsson B., de Man P., et al.: Intestinal colonization with enterobacteriaceae in Pakistani and Swedish hospital - delivered infants. Acta Paediatr Scand 1991; 80: 602-610.
2. Cukrowská B., Lodinová- Žádníková R., Sokol D., Tlaskalová H.: In vitro immunoglobulin response of fetal B cells is influenced by perinatal infections: study in preterm infants. Europ J Ped 1999; 158: 463-468.
3. Havenaar R., Huis Veld M. J. H. Probiotics: a general view. In: Lactic acid bacteria in health and disease. Vol 1. Amsterdam: Elsevier Applied Science Publishers, 1992.
4. Isolauri E., Grönland M. M, Salminen S., et al.: Why don't we bud? J Pediatr Gastroent 2000; 30: 214-216.
5. Isolauri E., Sütas Y., Kankaanpää P., et al.: Probiotics: effects of immunity. Am J Cliin Nutr 2001; 73 (suppl): 444S-450S.
6. Jirapongsananuruk O., Leung D. M. Y. Clinical applications of cytokines: new directions in the therapy of atopic diseases. Ann Allergy Immunol 1997; 79: 5-20.
7. Jones C. A., Holloway J. A., Warner J. O.: Does atopic disease start in foetal life? Allergy 2000; 55: 2-10.
8. Kalliomaki M., Salminen S., Arvilommi H., et al.: Probiotics in primary prevention of atopic disease: a randomized placebo-controlled trial. Lancet 2001; 357: 1076-1079.
9. Kitajama H., Sumida Y., Tanaka R., et al.: Early administration of Bifidobacterium breve to preterm infants: randomized controlled trial. Arch Dis Child 1997; 76: F101-F107.
10. Labeta M. O., Vidal K., Nores J. E., et al.: Innate recognition of bacteria in human milk is mediated by a milk/derived highly expressed pattern recognition receptor, soluble CD14. J Exp Med 2000; 191 (10): 1807-1812.
11. Lari A. R., Gold F., Borderon J. C., et al.: Implantation and in vivo antagonistic effects of antibiotic-susceptible Escherichia coli strains administered to premature newborns. Biol Neonate 1990; 58: 73-78.
12. Lodinová-Žádníková, R., Sonnenborn U.: Effect of preventive administration of a nonpathogenic Escherichia coli strain on the colonization of the intestine with microbial pathogens in newborn infants. Biol Neonate 1997; 71: 224-232.
13. Lodinová-Žádníková R., Slavíková M., Tlaskalova -Hogenová H., et al.: The antibody response in breast-fed and non-breast-fed infants after artificial colonization of the intestine with E.coli 083. Pediatr Res 1991; 29: 396-399.
14. Lodinová-Žádníková R., Tlaskalová H., Korych B., Bartáková Z.: The antibody response in infants after oral administration of inactivated and living E. coli vaccines and their protective effect against nosocomial infections. Adv Mucosal Immunol (ed. Mestecky J) Plenum Press, New York 1995; 1434-1438.
15. Lodinová-Žádníková R., Cukrowská B., Tlaskalová-Hogenová II.: Oral administration of probiotic Escherichia coli after birth reduces frequency of allergies and repeated infections later in life (after 10 and 20 years). Int Arch Allergy Immunol 2003; 131: 209-211.
16. Mestecky J., Russel M. V., Elson C. O.: Intestinal IgA: novel views on its function in the defence of the largest mucosal surface. Gut 1999; 44: 2-5.
17. Poisson D. M., Borderon J. C., Amorim-Sena J. C.: Evolution of the barrier effects against an exogenous drug-sensitive Escherichia coli strain after single or repeated oral administration to newborns and infants aged up to three months admitted to an intensive care unit. Biol Neonate 1986; 49: 1-7.
18. Rautava S., Kalliomaki M., Isolauri E.: Probiotics during pregnancy and breast-feeding might confer immunomodulatory protection against atopic disease in the infant. J Allergy Clin Immunol 2002; 109: 119-121.
19. Sudo N., Sawamura S., Tanaka K., et al.: The requirement of intestinal bacterial flora for the development of an IgE system fully susceptible to oral tolerance induction. J Immunol 1997; 159: 1739-1745.
20. Thompson P.J., Greenough A., Hird M. F., et al: HR. Nosocomial bacterial infections in very low birth-weight infants. Eur J Pediatr 1992; 151: 451-454.